Managing Osteoporosis and Fragility Fractures An Italian perspective
These revised guidelines from the Italian Inter-Society Commission for Osteoporosis provide practical indications for the management of osteoporosis and for the diagnosis, prevention and treatment of fragility fractures. This is a shortened version of the original article.
Modern Medicine ā Issue 6 2021
Absolute Fracture Risk What does it mean for your patient? ā MM1604
Fracture prevention is the main goal of treatment for osteoporosis. AbsoluteĀ fracture risk calculators have been developed that aim to better quantify fractureĀ risk and may help to guide treatment decisions in certain situations. It may alsoĀ help to clarify situations of low absolute fracture risk where treatment is notĀ indicated.
Absolute fracture risk calculators incorporate clinical risk factors as wellĀ as bone mineral density into risk estimations. Commonly used fracture riskĀ calculators are the WHO Fracture Risk Assessment Tool (FRAX) and theĀ Garvan Fracture Risk Calculator (GFRC).
Modern Medicine ā AprilĀ 2016
Factors Influencing Vitamin D Status in Urban African Black and Asian-Indian AdultsĀ ā MM1507
Vitamin D deficiency has been implicated in the aetiology ofĀ numerous infectious diseases and metabolic syndrome which areĀ prevalent in the African and Asian-Indian populations of SouthĀ Africa. There is limited data on 25-hydroxyvitamin D concentrationsĀ and limited comparative bone mineral density data on non-Ā Caucasian population groups in South Africa.
Modern Medicine ā July 2015
Why Use Parenteral Therapies for Osteoporosis?Ā ā MM1507
Treatment options for osteoporosis have dramatically changedĀ over the past 15 years. The newer parenteral therapies, zoledronicĀ acid and teriparatide, are effective treatment options with differingĀ mechanisms of action. Here we review these new agents andĀ compare their relative merits with existing oral medications forĀ osteoporosis.
Modern Medicine ā July 2015
Fracture Risk Reduction in Glucocorticoid-induced OsteoporosisĀ ā MM1411
Patients requiring more than three months of glucocorticoid therapyĀ should be assessed with regards to their fracture risk. CalciumĀ and vitamin D supplementation is recommended as preventiveĀ therapy for all patients taking glucocorticoids, and pharmacologicalĀ intervention should also be considered.
Modern Medicine ā November/DecemberĀ 2014
